BioCentury
ARTICLE | Clinical News

MORAb-004 regulatory update

June 13, 2011 7:00 AM UTC

FDA granted Orphan Drug designation for MORAb-004 from Eisai's Morphotek Inc. subsidiary to treat soft tissue sarcoma (STS). The humanized IgG mAb against CD248 endosialin (TEM1) is in Phase I testi...